Ranking Profile - Innovent Biologics Inc

Introduction

Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that carries out the research, development and manufacturing of monoclonal antibodies. It provides products for various diseases such as metabolic, cancer, autoimmune diseases and other therapeutic areas. The company's oncology products include sintilimab injection, bevacizumab injection, rituximab injection, pemigatinib, olverembatinib, ramucirumab, and others. Its autoimmune drugs are adalimumab injection, IBI-353, IBI-112 and IBI-314, among others. The company's metabolic and ophthalmology products include IBI-306, IBI-362, IBI-302, IBI-324, IBI-311 IGF-1R and IBI-333, among others. Innovent Biologics is headquartered in Suzhou, Jiangsu, China.